EPIQ Series Diagnostic Ultrasound System vs CVI42
AI Verdict
Choose EPIQ Series Diagnostic Ultrasound System if…
Choose the Philips EPIQ Series Diagnostic Ultrasound System if your facility requires a versatile, premium ultrasound solution for real-time imaging and immediate diagnostic confidence across a wide array of clinical applications. This system excels in scenarios demanding AI-powered image acquisition, advanced workflow automation, and precise measurements for specialties ranging from OB/GYN and pediatrics to emergency medicine and general radiology.
View EPIQ Series Diagnostic Ultrasound System →Choose CVI42 if…
Choose CVI42 if your cardiology or cardiothoracic surgery department needs an advanced software platform for in-depth, post-acquisition analysis of cardiac and vascular CT and MRI images. This tool is specifically designed for detailed quantification of coronary plaque, advanced CMR automation, and vascular planning, making it suitable for complex case assessment and research.
View CVI42 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EPIQ Series Diagnostic Ultrasound System | CVI42 |
|---|---|---|
| Pricing | Unknown | Starts at $5,000 per license. |
| Deployment | Unknown | On-premise (standalone workstation or client/server) |
| FDA Status | Unknown | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools prioritize user-friendliness and automation. The Philips EPIQ system offers advanced workflow solutions and a modern, tablet-like interface for intuitive image acquisition. CVI42, a software platform, is praised for its user-friendly interface and AI-driven automation that simplifies complex post-processing and analysis of cardiac images.
Clinical Value
CVI42While the Philips EPIQ provides premium AI-powered imaging and enhanced diagnostic confidence across diverse clinical applications, CVI42 offers more specialized and in-depth quantitative analysis. CVI42's FDA-cleared AI-enabled coronary plaque analysis provides fast, accurate, and reproducible quantification, significantly enhancing diagnosis and treatment planning for complex cardiovascular diseases.
Pricing & Value
CVI42The Philips EPIQ system represents a significant capital expenditure, with new systems requiring negotiated enterprise pricing. In contrast, CVI42 offers a flexible subscription model that scales with usage and service lines. Furthermore, the new Category I CPT code for AI-enabled quantitative plaque analysis directly supports reimbursement for CVI42's services, offering a clearer and potentially more sustainable financial value proposition.
Enterprise Readiness
EPIQ Series Diagnostic Ultrasound SystemPhilips EPIQ explicitly states HIPAA compliance and FDA clearance in its structured facts, backed by Philips' reputation as a global medical device leader. While CVI42 has obtained multiple FDA 510(k) clearances for its modules and offers DICOM/HL7 integration, the lack of explicit HIPAA compliance and BAA disclosure in its provided facts gives Tool A a slight edge in regulatory assurance for large enterprises.
Innovation
CVI42CVI42 demonstrates more cutting-edge innovation in AI-driven *analysis* of complex cardiac and vascular imaging. Its unified platform for Cardiac MRI and CT, comprehensive AI-automated plaque analysis, advanced CMR automation, and research-use PCAT analysis represent significant advancements in image interpretation and quantification. Philips EPIQ, while innovative in ultrasound hardware and real-time imaging, focuses on a different aspect of AI application.
Support & Docs
EPIQ Series Diagnostic Ultrasound SystemPhilips, as a large, established multinational corporation, offers a demonstrably more extensive and formalized support infrastructure. This includes dedicated professional resource centers, comprehensive documentation (user manuals, technical descriptions), and various technical support channels and clinical education services globally. While CVI42 provides technical support and documentation, Philips' scale and long-standing presence offer a more robust support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EPIQ Series Diagnostic Ultrasound System | CVI42 |
|---|---|---|
| Name | EPIQ Series Diagnostic Ultrasound System | CVI42 |
| Company | Philips Ultrasound | CIRCLE CARDIOVASCULAR IMAGING |
| Tagline | Redefining premium ultrasound performance with AI-powered imaging and smarter workflows for enhanced diagnostic confidence. | One Platform for All Your Advanced Cardiac Imaging Needs |
| Categories | Cardiology AI, OB/GYN AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Key Features (partial) | nSIGHT Imaging Architecture, PureWave Crystal Technology, xMATRIX Transducer Technology | AI-automated coronary lumen and wall segmentation, Comprehensive coronary plaque analysis (calcified, non-calcified, low-attenuation), Advanced CMR automation (T1 mapping, 4D flow pre-processing) |
Videos
Demos, reviews, and walkthroughs featuring EPIQ Series Diagnostic Ultrasound System and CVI42.